These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32416576)

  • 1. Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations.
    Kamata K; Otsuka Y; Imamura K; Oishi A; Kondo T; Suga M; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Yasukawa T; Usui H; Muguruma K; Tsujikawa A; Inoue H
    Stem Cell Res; 2020 May; 45():101782. PubMed ID: 32416576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Best disease-derived induced pluripotent stem cell line (FRIMOi006-A) carrying a novel dominant mutation in BEST1 gene.
    Domingo-Prim J; Riera M; Abad-Morales V; Ruiz-Nogales S; Corcostegui B; Pomares E
    Stem Cell Res; 2019 Oct; 40():101570. PubMed ID: 31518904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells from a patient with Best Dystrophy carrying 11q12.3 (BEST1 (VMD2)) mutation.
    Hsu CC; Lu HE; Chuang JH; Ko YL; Tsai YC; Tai HY; Yarmishyn AA; Hwang DK; Wang ML; Yang YP; Chen SJ; Peng CH; Chiou SH; Lin TC
    Stem Cell Res; 2018 May; 29():134-138. PubMed ID: 29660606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine-based Curcumin Approach Improved ROS Damage in Best Dystrophy-specific Induced Pluripotent Stem Cells.
    Lin TC; Lin YY; Hsu CC; Yang YP; Yang CH; Hwang DK; Wang CY; Liu YY; Lo WL; Chiou SH; Peng CH; Chen SJ; Chang YL
    Cell Transplant; 2019 Nov; 28(11):1345-1357. PubMed ID: 31313605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an induced pluripotent stem cell line (FDEENTi002-A) from a patient with Best's disease carrying c.888C > A mutation in BEST1 gene.
    Bai X; Yang XJ; Chen L
    Stem Cell Res; 2019 Jul; 38():101459. PubMed ID: 31146250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE.
    Moshfegh Y; Velez G; Li Y; Bassuk AG; Mahajan VB; Tsang SH
    Hum Mol Genet; 2016 Jul; 25(13):2672-2680. PubMed ID: 27193166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies.
    Nachtigal AL; Milenkovic A; Brandl C; Schulz HL; Duerr LMJ; Lang GE; Reiff C; Herrmann P; Kellner U; Weber BHF
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced Pluripotent Stem Cell Modeling of Best Disease and Autosomal Recessive Bestrophinopathy.
    Lee JH; Oh JO; Lee CS
    Yonsei Med J; 2020 Sep; 61(9):816-825. PubMed ID: 32882766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bestrophin1: A Gene that Causes Many Diseases.
    Smith JJ; Nommiste B; Carr AF
    Adv Exp Med Biol; 2019; 1185():419-423. PubMed ID: 31884648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-Onset Vitelliform Macular Dystrophy caused by BEST1 p.Ile38Ser Mutation is a Mild Form of Best Vitelliform Macular Dystrophy.
    Jun I; Lee JS; Lee JH; Lee CS; Choi SI; Gee HY; Lee MG; Kim EK
    Sci Rep; 2017 Aug; 7(1):9146. PubMed ID: 28831140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell line, BRCi004-A, derived from a patient with age-related macular degeneration.
    Kamata K; Otsuka Y; Imamura K; Oishi A; Kondo T; Suga M; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Yasukawa T; Usui H; Muguruma K; Tsujikawa A; Inoue H
    Stem Cell Res; 2020 May; 45():101787. PubMed ID: 32416577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant Best1 Expression and Impaired Phagocytosis in an iPSC Model of Autosomal Recessive Bestrophinopathy.
    Marmorstein AD; Johnson AA; Bachman LA; Andrews-Pfannkoch C; Knudsen T; Gilles BJ; Hill M; Gandhi JK; Marmorstein LY; Pulido JS
    Sci Rep; 2018 Mar; 8(1):4487. PubMed ID: 29540715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variations in Bestrophin‑1 and associated clinical findings in two Chinese patients with juvenile‑onset and adult‑onset best vitelliform macular dystrophy.
    Lin Y; Li T; Ma C; Gao H; Chen C; Zhu Y; Liu B; Lian Y; Huang Y; Li H; Wu Q; Liang X; Jin C; Huang X; Ye J; Lu L
    Mol Med Rep; 2018 Jan; 17(1):225-233. PubMed ID: 29115605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of new BEST1 variants identified in Italian patients with best vitelliform macular dystrophy assessed by computational structural biology.
    Frecer V; Iarossi G; Salvetti AP; Maltese PE; Delledonne G; Oldani M; Staurenghi G; Falsini B; Minnella AM; Ziccardi L; Magli A; Colombo L; D'Esposito F; Miertus J; Viola F; Attanasio M; Maggio E; Bertelli M
    J Transl Med; 2019 Oct; 17(1):330. PubMed ID: 31570112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration.
    Singh R; Shen W; Kuai D; Martin JM; Guo X; Smith MA; Perez ET; Phillips MJ; Simonett JM; Wallace KA; Verhoeven AD; Capowski EE; Zhang X; Yin Y; Halbach PJ; Fishman GA; Wright LS; Pattnaik BR; Gamm DM
    Hum Mol Genet; 2013 Feb; 22(3):593-607. PubMed ID: 23139242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human iPSC Modeling Reveals Mutation-Specific Responses to Gene Therapy in a Genotypically Diverse Dominant Maculopathy.
    Sinha D; Steyer B; Shahi PK; Mueller KP; Valiauga R; Edwards KL; Bacig C; Steltzer SS; Srinivasan S; Abdeen A; Cory E; Periyasamy V; Siahpirani AF; Stone EM; Tucker BA; Roy S; Pattnaik BR; Saha K; Gamm DM
    Am J Hum Genet; 2020 Aug; 107(2):278-292. PubMed ID: 32707085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations.
    Shah M; Broadgate S; Shanks M; Clouston P; Yu J; MacLaren RE; Németh AH; Halford S; Downes SM
    JAMA Ophthalmol; 2020 May; 138(5):544-551. PubMed ID: 32239196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation and Restoration of BEST1 Activity in Patient-derived RPEs with Dominant Mutations.
    Ji C; Li Y; Kittredge A; Hopiavuori A; Ward N; Yao P; Fukuda Y; Zhang Y; Tsang SH; Yang T
    Sci Rep; 2019 Dec; 9(1):19026. PubMed ID: 31836750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel BEST1 gene mutations associated with two different forms of macular dystrophy in Tunisian families.
    Chibani Z; Abid IZ; Molbaek A; Söderkvist P; Feki J; Hmani-Aifa M
    Clin Exp Ophthalmol; 2019 Nov; 47(8):1063-1073. PubMed ID: 31254423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Novel p.Tyr284Cys BEST1 genotype-phenotype correlations of Vitelliform Macular Dystrophy in a family with incomplete penetrance".
    Garza-Garza LA; León-Cachón RBR; Aguirre-Garza M; Garza-Leon M
    Ophthalmic Genet; 2020 Apr; 41(2):183-188. PubMed ID: 32207364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.